News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Geena Kludjian, PharmD

Advertisement

Geena Kludjian, PharmD, is an infectious diseases clinical pharmacy specialist at Cooper University Hospital in Camden, New Jersey.

Articles by Geena Kludjian, PharmD

Ibrexafungerp: A Novel Antifungal Agent That Is Easier to Pronounce Than Spell

ByGeena Kludjian, PharmD,Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
August 18th 2021
Advertisement

Latest Updated Articles

  • Ibrexafungerp: A Novel Antifungal Agent That Is Easier to Pronounce Than Spell
    Ibrexafungerp: A Novel Antifungal Agent That Is Easier to Pronounce Than Spell

    Published: August 18th 2021 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Measles Update: January 30, 2026

2

Top Infectious Disease News Stories Week of January 24 - January 30

3

Vaccines and Febrile Seizures: What Everyone Should Know

4

AAP Releases its Recommended 2026 Childhood and Adolescent Immunization Schedule

5

Fedora Pharmaceuticals Highlights First-in-Class Antibiotic at Conference

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us